![methyl 1-(beta-D-glucopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F350053-loganin.webp&w=3840&q=75)
CAS 18524-94-2
:metil 1-(beta-D-glucopiranosiloxi)-6-hidroxi-7-metil-1,4a,5,6,7,7a-hexahidrociclopenta[c]pirano-4-c
Descripción:
metil 1-(beta-D-glucopiranosiloxi)-6-hidroxi-7-metil-1,4a,5,6,7,7a-hexahidrociclopenta[c]pirano-4-carboxilato, identificado por el número CAS 18524-94-2, es un compuesto orgánico complejo caracterizado por sus características estructurales únicas. Contiene un anillo de ciclopentano fusionado con una porción de pirano, lo que contribuye a su naturaleza cíclica y potencial actividad biológica. La presencia de un grupo metilo y una porción de glucopiranosilo indica que puede exhibir solubilidad en disolventes polares y podría participar en enlaces de hidrógeno debido a los grupos hidroxilo. Este compuesto también puede poseer propiedades glucósidas, lo que sugiere aplicaciones potenciales en química medicinal o como un glucósido. Su complejidad estructural puede influir en su reactividad, estabilidad e interacción con sistemas biológicos. Además, la presencia de múltiples grupos funcionales, incluidos hidroxilo y carboxilato, sugiere que podría estar involucrado en varias reacciones químicas, lo que lo convierte en un tema de interés para futuras investigaciones en síntesis orgánica y farmacología. En general, este compuesto ejemplifica la intrincada relación entre estructura y función en la química orgánica.
Fórmula:C17H26O10
InChI:InChI=1S/C17H26O10/c1-6-9(19)3-7-8(15(23)24-2)5-25-16(11(6)7)27-17-14(22)13(21)12(20)10(4-18)26-17/h5-7,9-14,16-22H,3-4H2,1-2H3/t6-,7+,9-,10+,11+,12+,13-,14+,16-,17-/m0/s1
Clave InChI:InChIKey=AMBQHHVBBHTQBF-UOUCRYGSSA-N
SMILES:O([C@H]1[C@]2([C@@](C(C(OC)=O)=CO1)(C[C@H](O)[C@@H]2C)[H])[H])[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
Sinónimos:- (1S)-1α-(β-<span class="text-smallcaps">D</span>-Glucopyranosyloxy)-1,4aα,5,6,7,7aα-hexahydro-6α-hydroxy-7α-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester
- 7-Hydroxy-6-desoxyverbenalin
- Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methyl-, methyl ester
- Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methyl-, methyl ester, (1S,4aS,6S,7R,7aS)-
- Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methyl-, methyl ester, [1S-(1α,4aα,6α,7α,7aα)]-
- Loganin
- Loganoside
- Methyl 1-(Hexopyranosyloxy)-6-Hydroxy-7-Methyl-1,4A,5,6,7,7A-Hexahydrocyclopenta[C]Pyran-4-Carboxylate
- NSC 606403
- methyl (1S,4aS,6S,7R,7aS)-1-(beta-D-glucopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
- methyl (1S,4aS,6S,7R,7aS)-1-(hexopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
- Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methyl-, methyl ester, [1S-(1α,4aα,6α,7α,7aα)]-
- (1S)-1α-(β-D-Glucopyranosyloxy)-1,4aα,5,6,7,7aα-hexahydro-6α-hydroxy-7α-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester
- Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methyl-, methyl ester
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 11 productos.
Loganin
CAS:Loganin analytical standard provided with w/w absolute assay, to be used for quantitative titration.Fórmula:C17H26O10Pureza:(HPLC) ≥99%Forma y color:PowderPeso molecular:390.39Cyclopenta[c]pyran-4-carboxylic acid,1-(b-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methyl-, methyl ester, (1S,4aS,6S,7R,7aS)-
CAS:Fórmula:C17H26O10Pureza:98%Forma y color:SolidPeso molecular:390.3823Loganin
CAS:Fórmula:C17H26O10Pureza:≥ 97.0%Forma y color:White to off-white powderPeso molecular:390.38Loganin
CAS:Fórmula:C17H26O10Pureza:>98.0%(HPLC)(qNMR)Forma y color:White to Almost white powder to crystalPeso molecular:390.39Loganin
CAS:Loganin is a non-competitive inhibitor of BACE1 with IC50 of 47.97 μM an also inhibits AChE and BChE with IC50 values of 3.95 μM and 33.02 μM, respectively. Loganin has neuroprotective, anti-amnesic, anti-inflammatory and anti-shock effects, it also exhibits protective effects against hepatic injury and other diabetic complications associated with abnormal metabolic states and inflammation caused by oxidative stress and advanced glycation endproduct formation. Loganin can attenuate neuroinflammatory responses through the inactivation of NF-κB by NF-κB dependent inflammatory pathways and phosphorylation of MAPK in Aβ25-35-induced PC12 cells, and can protect against hydrogen peroxide-induced apoptosis by inhibiting phosphorylation of JNK, p38, and ERK 1/2 MAPKs in SH-SY5Y cells.Fórmula:C17H26O10Pureza:95%~99%Peso molecular:390.385Loganin
CAS:<p>Loganin inhibits Cox-1, suppresses TNF-α, and has antioxidant and anti-melanogenic properties.</p>Fórmula:C17H26O10Pureza:99.01% - >99.99%Forma y color:White PowderPeso molecular:390.38Loganin
CAS:Natural glycosideFórmula:C17H26O10Pureza:≥ 95.0 % (HPLC)Forma y color:PowderPeso molecular:390.39Loganin
CAS:<p>Loganin is a bioactive iridoid compound, which is a type of secondary metabolite typically found in plants. It is primarily derived from sources such as the genera Strychnos and Gentiana, among others. Loganin operates through various biological pathways, influencing enzymatic and receptor activities that contribute to its pharmacological effects. These activities include anti-inflammatory, antioxidant, and neuroprotective actions, making Loganin a compound of interest in several areas of medical research.</p>Fórmula:C17H26O10Pureza:Min. 94 Area-%Forma y color:PowderPeso molecular:390.39 g/molLoganin
CAS:Producto controlado<p>Applications An iridoid glycoside that exhibits protective effects against hepatic injury and other diabetic complications associated with abnormal metabolic states and inflammation caused by oxidative stress and advanced glycation endproduct formation. A potential anti-amnesic agent.<br>References Yamabe, N. et al.: Eur. J. Pharmmacol., 648, 179 (2010); de Carman Recio, M. et al.: Planta Medica, 3, 232 (1994); Kwon, S. et al.: Eur. J. Pharmacol., 619, 44 (2009);<br></p>Fórmula:C17H26O10Forma y color:NeatPeso molecular:390.38
![Cyclopenta[c]pyran-4-carboxylic acid,1-(b-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA00I1JK.jpg&w=3840&q=75)
